Current Report Filing (8-k)
May 13 2020 - 9:31AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
May
13, 2020
Date
of Report
(Date
of earliest event reported)
OZOP
SURGICAL CORP.
(Exact
name of registrant as specified in its charter)
Nevada
|
|
000-55976
|
|
35-2540672
|
(State or other jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
31
Sandfort Ln., Warwick NY 10990
(Address
of principal executive offices, including zip code)
(845)
544-5112
(Registrant’s
telephone number, including area code)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
Written communications pursuant to Rule 425 under the Securities Act
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
N/A
|
|
N/A
|
|
N/A
|
Item
7.01 Regulation FD Disclosure.
On
May 13, 2020, Ozop Surgical Corp. (the “Company”) issued a press release regarding the reduction of its convertible
noteholders. A copy of the press release issued by the Company is attached as Exhibit 99.1 to this Current Report on Form 8-K,
which is incorporated by reference solely for purposes of this Item 7.01 disclosure.
Exhibit
99.1 contains forward-looking statements. These forward-looking statements are not guarantees of future performance and involve
risks, uncertainties and assumptions that are difficult to predict. Forward-looking statements are based upon assumptions as to
future events that may not prove to be accurate. Actual outcomes and results may differ materially from what is expressed in these
forward-looking statements
The
information set forth under this Item 7.01, including Exhibit 99.1, is being furnished and, as a result, such information shall
not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or otherwise subject to the liabilities of such Section, nor shall such information be deemed incorporated by reference
in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference
in such a filing.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Report to be signed on its behalf
by the undersigned hereunto duly authorized.
Dated:
May 13, 2020
|
OZOP
SURGICAL CORP.
|
|
|
|
|
By:
|
/s/
Brian Conway
|
|
Name:
|
Brian
Conway
|
|
Title:
|
Chief
Executive Officer
|
Ozop Energy Solutions (PK) (USOTC:OZSC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ozop Energy Solutions (PK) (USOTC:OZSC)
Historical Stock Chart
From Sep 2023 to Sep 2024